Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2014

01-03-2014 | UNM Clinical Case Conferences

The Clinical Course of Acute Hepatitis C

Authors: Allison Venner, Martin Kistin

Published in: Digestive Diseases and Sciences | Issue 3/2014

Login to get access

Abstract

A 42-year-old woman developed epigastric abdominal pain and acutely elevated serum transaminase levels during a course of chemotherapy for breast cancer. Serum antibodies to hepatitis A, B and C were not identified initially, but subsequently a high hepatitis C viral load was detected. Ultrasonic imaging of the liver was normal. Serum transaminase elevations resolved within 2 months, and, after 6 months without therapy, the hepatitis C viral load became undetectable.
Literature
2.
go back to reference Sanantonio T, Wiegand J, Tilman-Gerlach JT. Acute hepatitis C: current status and remaining challenges. J Hepatol. 2008;49:625–633.CrossRef Sanantonio T, Wiegand J, Tilman-Gerlach JT. Acute hepatitis C: current status and remaining challenges. J Hepatol. 2008;49:625–633.CrossRef
4.
go back to reference Loomba R, Rivera M, McBurney R, Hayes-Williams B, et al. The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes. Aliment Pharmacol Ther. 2011;33:559–565.PubMedCrossRef Loomba R, Rivera M, McBurney R, Hayes-Williams B, et al. The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes. Aliment Pharmacol Ther. 2011;33:559–565.PubMedCrossRef
5.
go back to reference Licata A, Di Bona, Schepis F. When and how to treat acute hepatitis C. J Hepatol. 2003;39:1056–1062.PubMedCrossRef Licata A, Di Bona, Schepis F. When and how to treat acute hepatitis C. J Hepatol. 2003;39:1056–1062.PubMedCrossRef
6.
go back to reference Kamal SM, Fouly AE, Kamel RR, Hockenjos B, et al. Peginterferon alpha-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology. 2006;130:632–638.PubMedCrossRef Kamal SM, Fouly AE, Kamel RR, Hockenjos B, et al. Peginterferon alpha-2b therapy in acute hepatitis C: impact of onset of therapy on sustained virologic response. Gastroenterology. 2006;130:632–638.PubMedCrossRef
8.
go back to reference Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012;57(6):1177–1185. doi:10.1016/j.jhep.2012.07.031. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol. 2012;57(6):1177–1185. doi:10.​1016/​j.​jhep.​2012.​07.​031.
9.
go back to reference Gentile I, De Stefano A, Di Flumeri G, et al. Concomitant interferon-alpha and chemotherapy in hepatitis C and colorectal cancer: a case report. In Vivo.. 2013;27:527–529.PubMed Gentile I, De Stefano A, Di Flumeri G, et al. Concomitant interferon-alpha and chemotherapy in hepatitis C and colorectal cancer: a case report. In Vivo.. 2013;27:527–529.PubMed
Metadata
Title
The Clinical Course of Acute Hepatitis C
Authors
Allison Venner
Martin Kistin
Publication date
01-03-2014
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2014
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-014-3068-8

Other articles of this Issue 3/2014

Digestive Diseases and Sciences 3/2014 Go to the issue